Market Overview
The growth of the Pharmaceutical Glass Packaging Market is increasing at a faster rate. The pharmaceutical industry is booming due to the availability of crucial clinical drugs and other services, and the use of packaging is vital to protect these medicines. Glass packaging, in particular, is gaining popularity due to its advantages, such as protecting the product from contamination and damage, increasing its shelf life, and preventing carbon dioxide from entering the package.

The demand for pharmaceutical drugs and medicines is expected to be high in the coming years, leading to an increase in sales of pharmaceutical glass packaging. The segment of injectable medicines is experiencing the greatest demand, and the use of glass packaging helps to prevent the medicines from breaking down due to external factors..

Segment Overview
The growth of the Pharmaceutical Glass Packaging Market is fuelled by the growing demand for packaging in the pharmaceutical industry. Longer shelf life and advancements in packaging technology are factors contributing to market growth. The growth rate for vials is expected to be second highest after ampoules, driven by their high analytical performance and sustainability. Ampoules are expected to grow at a faster pace, and type III glass is projected to show significant growth. The generic drugs segment is expected to grow at the fastest rate.

Pharmaceutical glass bottles are categorized into two types based on size, small and large. Large bottles are used for packaging reagents, transfusion and infusion bottles, while small bottles are for syrup and oral liquid packaging. The small bottle segment is anticipated to grow due to new opportunities such as the increasing consumption of oral tablets packaged in small bottles.

Regional Analysis
North America plays a crucial role in the pharmaceutical glass packaging market, with strong investment in R&D and product innovation in the glass packaging sector. The demand for pharmaceutical glass packaging is fueled by stringent regulations and policies in the US and Canada, growing drug consumption, and the rapid growth of the pharmaceutical industry.

The US is the leading player in the North American pharmaceutical glass packaging market, as the rapidly expanding drug market drives a continuous increase in demand for glass packaging in the pharmaceutical sector. The growth of the pharmaceutical glass packaging market in the US is further supported by the rising healthcare spending in the country.

Major Players
The key players in the market are Shandong Qidu Pharmaceutical Co.,Ltd. (China), West Pharmaceutical Services, Inc. (U.S.), SCHOTT Pharmaceutical Packaging (U.S.), Ardagh Group S.A. (Luxembourg), Piramal Glass (India), Bormioli Rocco SpA (Italy), Nipro Corporation (Japan), SGD Pharma (France), and Stölzle-Oberglas Gmbh (Austria) and Gerresheimer AG (Germany).

COVID 19 Impacts
The COVID-19 pandemic has left a lasting impact on the pharmaceutical industry, causing steady growth and high demand for medical supplies and treatments. The sudden increase in demand for pharmaceutical drugs due to the pandemic has positively affected the market, and it is expected to reach new heights once COVID-19 vaccines are approved and distributed globally.

For example, the United States is producing millions of surplus vaccine doses packaged in large multi-dose vials, which are either used domestically or exported to other countries. has posed challenges for manufacturers, despite the demand from state officials.

Currently, most vaccines in the U.S. are distributed in the form of single-dose vials or prefilled syringes. However, the COVID-19 vaccines were initially distributed through multi-dose vials due to the urgency and quick production needed during the early months of the inoculation campaign in the country.

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

1.1 EXECUTIVE SUMMARY

1.1.1 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT

1.1.2 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL TYPE

1.1.3 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION

1.1.4 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS

3.2 PRIMARY RESEARCH

3.3 SECONDARY RESEARCH

3.4 MARKET SIZE ESTIMATION

3.5 FORECAST MODEL

3.6 LIST OF ASSUMPTIONS

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 EXTENDING THE SHELF LIFE OF PRODUCTS

4.2.2 TECHNOLOGICAL DEVELOPMENTS IN PHARMACEUTICAL GLASS PACKAGING

4.2.3 INCREASING DEMAND FROM THE PHARMACEUTICAL INDUSTRY

4.2.4 DRIVERS IMPACT ANALYSIS

4.3 RESTRAINT

4.3.1 GROWING DEMAND FOR PLASTIC PACKAGING

4.3.2 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITY

4.4.1 INCREASING DEMAND IN EMERGING ECONOMIES

4.5 REGULATORY FRAMEWORK

4.5.1 ASPECTS OF PACKAGING

4.5.1.1 GENERAL CONSIDERATIONS

4.5.1.2 COMPLIANCE

4.5.2 PACKAGING MATERIALS AND CLOSURES

4.5.3 QUALITY ASSURANCE ASPECTS OF PACKAGING

4.5.3.1 GENERAL CONSIDERATIONS

4.5.3.2 QUALITY CONTROL

4.5.3.2.1 SAMPLING

4.5.3.2.2 TESTING PROGRAMME

4.5.3.3 INSPECTION AND AUDIT

4.5.3.3.1 RULES

4.5.3.3.2 AUDITS OF SUPPLIERS

4.5.4 PROTECTION OF THE ENVIRONMENT

4.5.4.1 PACKAGING WASTE

4.5.4.2 WASTE POLICIES

4.6 PROFIT MARGIN ANALYSIS

4.7 RELATION BETWEEN CAPACITY UTILIZATION RATE & PRODUCT PRICES

4.7.1 LOW UTILIZATION

4.7.2 FULL UTILIZATION

4.7.3 OVER-UTILIZATION

4.8 CAPAPCITY UTILISATION ANALYSIS

4.8.1 AVERAGE CAPACITY UTILISATION RANGE OF PROMINENT PLAYERS, 2022-2030

4.8.2 ESTIMATED PLANNED AND FORECASTED CAPACITY EXPANSION BY PROMINENT PLAYERS

4.9 COVID-19 IMPACT ANALYSIS

4.9.1 ECONOMIC IMPACT

4.9.1.1 IMPACT ON THE OVERALL PACKAGING INDUSTRY

4.9.2 IMPACT ON PRODUCTION

4.9.3 IMPACT ON GLASS PACKAGING MARKET

4.9.3.1 IMPACT ON SUPPLY CHAIN

4.9.3.2 IMPACT ON RAW MATERIAL

4.9.3.3 CASH FLOW CONSTRAINTS

4.9.4 IMPACT ON WORLD TRADE

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS

5.1.1 RAW MATERIAL SUPPLY

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION CHANNELS

5.1.4 END USERS

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

6 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT

6.1 OVERVIEW

6.1.1 VIALS

6.1.2 BOTTLES & JARS

6.1.3 CARTRIDGES & SYRINGES

6.1.4 AMPOULES

7 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL TYPE

7.1 OVERVIEW

7.1.1 TYPE I

7.1.2 TYPE II

7.1.3 TYPE III

8 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION

8.1 OVERVIEW

8.1.1 GENERIC DRUGS

8.1.2 BRANDED DRUGS

8.1.3 BIOLOGICAL DRUGS

9 GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.2.3 MEXICO

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 REST OF ASIA-PACIFIC

9.5 LATIN AMERICA

9.5.1 BRAZIL

9.5.2 ARGENTINA

9.5.3 REST OF LATIN AMERICA

9.6 MIDDLE EAST & AFRICA

9.6.1 UAE

9.6.2 SAUDI ARABIA

9.6.3 SOUTH AFRICA

9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION

10.2 COMPETITIVE OVERVIEW

10.3 MARKET SHARE ANALYSIS

10.4 COMPETITIVE BENCHMARKING

10.5 GERRESHEIMER AG: LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS

10.6.2 EXPANSIONS

10.6.3 MERGERS & ACQUISITIONS/INVESTMENTS

10.6.4 PARTNERSHIPS/CONTRACTS & AGREEMENTS

11 COMPANY PROFILES

11.1 GERRESHEIMER AG

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 NIPRO CORPORATION

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 SCHOTT AG

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 SGD PHARMA

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.5 SHANDONG QIDU PHARMACEUTICAL CO., LTD.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.6 BORMIOLI PHARMA S.P.A.

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.7 ARDAGH GROUP S.A.

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 WEST PHARMACEUTICAL SERVICES, INC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 PIRAMAL ENTERPRISES LIMITED

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 STOELZLE OBERGLAS GMBH

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.11 ARAB PHARMACEUTICAL GLASS CO.

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.12 ŞİŞECAM GROUP

11.12.1 COMPANY OVERVIEW

11.12.2 FINANCIAL OVERVIEW

11.12.3 PRODUCTS OFFERED

11.12.4 KEY DEVELOPMENTS

11.12.5 SWOT ANALYSIS

11.12.6 KEY STRATEGIES

11.13 OWENS-ILLINOIS INC.

11.13.1 COMPANY OVERVIEW

11.13.2 FINANCIAL OVERVIEW

11.13.3 PRODUCTS OFFERED

11.13.4 KEY DEVELOPMENTS

11.13.5 SWOT ANALYSIS

11.13.6 KEY STRATEGIES

11.14 BECTON, DICKINSON AND COMPANY

11.14.1 COMPANY OVERVIEW

11.14.2 FINANCIAL OVERVIEW

11.14.3 PRODUCTS OFFERED

11.14.4 KEY DEVELOPMENTS

11.14.5 SWOT ANALYSIS

11.14.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCE

Related Report: Global Pharmaceutical Glass Packaging Market Research Report – Forecast Till 2026

The post Global Pharmaceutical Glass Packaging Market Research Report Forecast to 2026 first appeared on CRI Report.

The global pharmaceutical glass packaging market is anticipated to surpass USD 13.5 billion by 2027 and is going to witness the highest CAGR of 6.9% by the end of 2026. Glass packaging is the safest way of packaging as the glass does not get contaminated and cause reactions.

Additionally, as compared to conventional plastic packaging, glass material can be recycled and reused and it has already exhibited various packaging-friendly properties such as sterility, chemical inertness, malleability, and water resistance.

The global pharmaceutical glass packaging market is anticipated to exhibit an incredible market expansion having the largest market value of USD 7.6 billion in 2020. The rising need for packaging, technological innovations, and demand for extending the shelf life of pharmaceutical products and other factors are expected to propel the overall growth of the global pharmaceutical industry.

However, the major market restraint is the increasing demand for plastic packaging as it has properties such as safety to handle and lightweight. Furthermore, the rising need for pharmaceutical glass packaging in developing countries is set to offer lucrative growth opportunities for the players operating in the global pharmaceutical glass packaging market during the review period.

Pharmaceutical Glass Packaging Market Segmentation

The global pharmaceutical glass packaging market has been classified into type, material, application, and region.

In terms of product type, the global pharmaceutical glass packaging market has been classified into vials, bottles & jars, cartridges & syringes, and ampoules. Based on material type, the pharmaceutical glass packaging market has been divided into type I, type II, and Type III. Based on application, the global market has been categorized into generic drugs, branded drugs, and biological drugs.

Pharmaceutical Glass Packaging Market Regional Analysis

The region-specific analysis of the global pharmaceutical glass packaging market is studied across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is one of the noticeable regions for the pharmaceutical glass packaging market. The area has seen expanded interests in R&D and item development all things considered. Rigid guidelines and approaches in the US and Canada expanded utilization of medications, and quick development of the pharmaceutical area are the components driving the interest for pharmaceutical glass packaging in the locale.

The US is the major market contributor to the global glass packaging market in North America.

In the US, the pharmaceutical glass packaging industry is seeing quick development. With the extending market for drugs, the interest in glass packaging increments persistently in the pharmaceutical business. Developing medical services spending is boosting the development of the pharmaceutical glass packaging market in the country.

Major Players of Pharmaceutical Glass Packaging Market

The leading players of the global pharmaceutical glass packaging market include Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass (Mumbai), Sisecam Group (Tuzla, TR), Owens-Illinois Inc. (US) in 2019.

Additionally, Gerresheimer AG (Germany), SGD Pharma (France), Bormioli Pharma S.p. (Italy), Ardagh Group S.A.(Luxembourg), West Pharmaceutical Services Inc. (US), and StoelzleOberglasGmbh (Austria) are developing as major players.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

E-Glass Market to Surge at 3.33% CAGR, which is anticipated to reach USD 39.4 billion by 2030.

The post Global Pharmaceutical Glass Packaging Market Research Report – Forecast Till 2026 first appeared on CRI Report.